The Patent Finder

OncoMEDx, Inc.

Also on record
Records under this name other than patents OncoMEDx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to OncoMEDx, Inc.

PatentTitleStatus Expires Confidence
US 7,767,390Methods for evaluating drug-resistance gene expression in the cancer patient
Term ended
Term ended Jul 27, 2024 · From the USPTO record
Term endedTerm ended Jul 27, 2024From the USPTO record
US 7,732,141Methods for evaluating drug-resistance gene expression in the cancer patient
Lapsed on the fee record
Ended Jun 8, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 8, 2022From the USPTO record
US 7,910,336Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
Term ended
Term ended Jun 8, 2019 · From the USPTO record
Term endedTerm ended Jun 8, 2019From the USPTO record
US 8,163,524Comparative analysis of extracellular RNA species
Term ended
Term ended Dec 16, 2018 · From the USPTO record
Term endedTerm ended Dec 16, 2018From the USPTO record
US 7,932,061Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma of serum to detect, monitor or evaluate cancer or premalignant conditions
Term ended
Term ended Oct 16, 2018 · From the USPTO record
Term endedTerm ended Oct 16, 2018From the USPTO record
US 6,329,179Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
Term ended
Term ended Sep 22, 2018 · From the USPTO record
Term endedTerm ended Sep 22, 2018From the USPTO record
US 7,767,422Detection of 5T4 RNA in plasma and serum
Lapsed on the fee record
Ended Aug 3, 2018 · From the USPTO record
Lapsed on the fee recordEnded Aug 3, 2018From the USPTO record
US 8,809,020Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma or serum to detect, monitor or evaluate cancer or premalignant conditions
Term ended
Term ended Jun 5, 2018 · From the USPTO record
Term endedTerm ended Jun 5, 2018From the USPTO record
US 7,785,842Comparative analysis of extracellular RNA species
Term ended
Term ended May 29, 2018 · From the USPTO record
Term endedTerm ended May 29, 2018From the USPTO record
US 7,709,233Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
Lapsed on the fee record
Ended May 4, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2018From the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited